Account
dentsu X bags digital mandate for Reckitt India
Mumbai: FMCG major Reckitt India has consolidated its entire media mandate including strategy and planning across offline and digital with dentsu X, the media agency from the house of dentsu India. The agency has been handing the offline media mandate for Reckitt India since 2020.
“The additional mandate of strategy and digital has been awarded to the agency following a comprehensive competitive pitch process,” said the statement.
“We are excited to expand our relationship with dentsu X,” said Reckitt South Asia senior VP Gaurav Jain. “They understand our brand, our vision and our way of working. We are confident that dentsu X will continue to assist us in engaging with our audience while also contributing to our commercial objectives.”
Speaking on the win, dentsu South Asia Media CEO Divya Karani commented, “This win certainly reflects our client’s confidence in dentsu’s ability to make a meaningful difference to their businesses.”
“This long-term partnership underlines Reckitt’s confidence in our expertise and we look forward to working with the brand on driving consumer centricity and innovations. With a distinct viewpoint on the evolving communication landscape, dentsu X believes in providing experiences that go beyond conventional media exposures. This consolidation certainly empowers us to drive the desired seamless consumer experience,” added dentsu X chief executive officer Roopam Garg.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
